Company Description

Scienture Holdings, Inc. operates as health services IT company.

It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics, and independent pharmacies.

Scienture Holdings, Inc. is headquartered in Tampa, Florida.

Scienture Holdings, Inc.

Country	United States
Founded	2010
IPO Date	Feb 13, 2020
Industry	Pharmaceutical Retailers
Sector	Healthcare
Employees	19
CEO	Surendra Ajjarapu

Contact Details

Address: 6308 Benjamin Rd, Suite 708 Tampa, Florida 33634 United States
Phone	(800) 261-0281
Website	scienture.com

Stock Details

Ticker Symbol	SCNX
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001382574
ISIN Number	US80880X1046
SIC Code	2834

Key Executives

Name	Position
Surendra K. Ajjarapu	Chairman and Chief Executive Officer
Prashant Patel R.Ph.	Interim Chief Financial Officer, Interim Principal Accounting Officer, President, Chief Operating Officer and Director
Rahul Surana M.B.A., Ph.D.	Executive Vice President and Chief Operating Officer of Scienture LLC

Latest SEC Filings

Date	Type	Title
Jan 17, 2025	8-K	Current Report
Jan 14, 2025	S-1/A	[Amend] General form for registration of securities under the Securities Act of 1933
Jan 8, 2025	8-K	Current Report
Dec 30, 2024	DEF 14C	Filing
Dec 20, 2024	PRE 14C	Filing
Dec 19, 2024	D	Notice of Exempt Offering of Securities
Dec 3, 2024	S-1	General form for registration of securities under the Securities Act of 1933
Nov 26, 2024	8-K	Current Report
Nov 6, 2024	10-Q	Quarterly Report
Nov 6, 2024	1-A/A	Filing

View All SEC Filings